Optimized "in vitro" culture conditions for human rheumatoid arthritis synovial fibroblasts.
Claudia CasniciDonatella LattuadaNoemi TonnaKatia CrottaClaudio StoriniFabio BiancoMarcello Claudio TruzziCostantino CorradiniOrnella MarelliPublished in: Mediators of inflammation (2014)
The composition of synovial fluid in rheumatoid arthritis (RA) is complex and strongly influences the microenvironment of joints and it is an inseparable element of the disease. Currently, "in vitro" studies are performed on RA cells cultured in the presence of either recombinant proinflammatory cytokines-conditioned medium or medium alone. In this study, we evaluated the use of synovial fluid, derived from RA patients, as optimal culture condition to perform "in vitro" studies on RA synovial fibroblasts. We observed that synovial fluid is more effective in inducing cell proliferation with respect to TNF-alpha or culture medium alone. Spontaneous apoptosis in fibroblasts was also decreased in response to synovial fluid. The expression of proinflammatory cytokines in the presence of synovial fluid was significantly elevated with respect to cells cultured with TNF-alpha or medium, and the overall morphology of cells was also modified. In addition, modulation of intracellular calcium dynamics elicited in response to synovial fluid or TNF-alpha exposure is different and suggests a role for the purinergic signalling in the modulation of the effects. These results emphasize the importance of using RA synovial fluid in "in vitro" studies involving RA cells, in order to reproduce faithfully the physiopathological environmental characteristic of RA joints.
Keyphrases
- rheumatoid arthritis
- cell cycle arrest
- disease activity
- induced apoptosis
- ankylosing spondylitis
- endoplasmic reticulum stress
- cell proliferation
- interstitial lung disease
- endothelial cells
- cell death
- end stage renal disease
- oxidative stress
- pi k akt
- stem cells
- signaling pathway
- chronic kidney disease
- cell cycle
- extracellular matrix
- case control
- poor prognosis
- long non coding rna
- climate change
- patient reported outcomes
- risk assessment
- pluripotent stem cells